Articles
Mesoblast MPCs improve outcomes in heart failure
Mesoblast's (ASX:MSB) mesenchymal precursor cells were associated with improved outcomes in end-stage heart failure patients needing to be weaned off LVADs during a recent trial. [ + ]
UBI gets first test-strip order from Siemens
Universal Biosensors (ASX:UBI) announced a milestone in its tie-up with Siemens Healthcare Diagnostics to develop point-of-care coagulation tests - the first commercial order for PT-INR strips. [ + ]
Bionomics licenses BNC375 for up to $558m
Bionomics (ASX:BNO) has signed a research collaboration and licensing deal with Merck covering BNC375, a treatment candidate for Alzheimer's and other CNS conditions. [ + ]
A spectroscopic technique for understanding photochemical reactions
Using photochemical reactions to our advantage requires a deep understanding of the interplay between the electrons and atomic nuclei within a molecular system after that system has been excited by light. [ + ]
First images of a microorganism's drug manufacturing line
Researchers at the University of Michigan (UM) have obtained the first three-dimensional snapshots of the 'assembly line' within microorganisms that naturally produces antibiotics and other drugs. [ + ]
Hunting for breast cancer risk with next-gen sequencing
The Hunter Medical Research Institute's (HMRI) Pathology Service laboratory has developed DNA sequencing technology that is accelerating screening for the genetic risk of breast and ovarian cancer. [ + ]
How application and workflow affect pipette selection
By choosing the right pipetting system and eliminating risk and variability from pipetting procedures, users can achieve enhanced accuracy, reduced costs and better overall productivity. [ + ]
Mesoblast's MPCs show promise in type 2 diabetes
Mesoblast (ASX:MSB) revealed its MPCs were able to improve glycaemic control during a phase II trial in type 2 diabetes. [ + ]
Novogen, CanTx establish proof of concept for Trx-1
Novogen (ASX:NRT) and its CanTx JV have published preclinical data supporting the potential of Trx-1, injected into the peritoneal cavity, as a first-line therapy for ovarian cancer. [ + ]
Getting personal with cancer
Recent work on developing targeted treatments for pancreatic cancer is paving the way for new approaches in personalised medicine. [ + ]
Biotech survey shows advanced manufacturing heading overseas
The annual Biotechnology Industry Position Survey (2014) shows a worrying trend: advanced manufacturing associated with this industry of the future is following traditional manufacturing and there has been a sharp increase in the number of companies heading overseas. [ + ]
Atomo wins Best In Show at MDEA
Atomo Diagnostics' HIV blood test, AtomoRapid HIV, has been named Best In Show at the Medical Design Excellence Awards. [ + ]
Eucalyptus genome successfully sequenced
The genetic blueprint of the Eucalyptus grandis (flooded gum) has been sequenced for the first time. The five-year effort to analyse the 640 million base-pair genome was conducted by 80 researchers from 30 institutions across 18 countries. [ + ]
UWA Professor named WA's Chief Scientist
Medical research luminary Professor Peter Klinken has taken the role of Western Australia's Chief Scientist and aims to change the state's research focus from oil and gas mining to biotechnology. [ + ]
Playing chicken with Campylobacter
Potentially deadly pathogenic strains of Salmonella and Escherichia coli get most of the headlines, but Professor Gary Dykes says most cases of non-lethal food poisoning in Australia are due to diners running afoul of poorly cooked chicken, and its microbial hanger-on, Campylobacter. [ + ]
